Business
CardioComm Solutions Continues to Expand into M-Health Markets with New ECG Monitoring License and Co-Marketing Agreement
TORONTO, ON / ACCESSWIRE / July 5, 2016 / Established medial electrocardiogram ("ECG") softw...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"CardioComm Solutions Continues to Expand into M-Health Markets with New ECG Monitoring License and Co-Marketing AgreementTORONTO, ON / ACCESSWIRE / July 5, 2016 / Established medial electrocardiogram (\"ECG\") software and device manufacturer CardioComm Solutions, Inc. (TSXV: EKG) (\"CardioComm Solutions\" or the \"Company\") today announced an ECG service license and co-marketing agreement for devices manufactured by China-based, BORSAM Biomedical Instruments CO., Ltd. (\"BORSAM\"), a medical-grade, ECG OEM device manufacturer. \nImage: https://www.accesswire.com/uploads/21390_a1467723520539_51a.jpg\nCannot view this image? Please visit [https://www.accesswire.com/uploads/21390_a1467723520539_51.jpg] to view this image\nThe announcement was made following completion of product compatibility testing of two Bluetooth handheld ECG devices and CardioComm Solutions' GEMS™ and GlobalCardio™ ECG management software platforms. Connectivity to iOS and Android Smartphones will be managed by a downloadable App designed by CardioComm Solutions and based on the Company's FDA cleared and Health Canada approved GEMS™ software. ECGs will be transmitted to Smartphones through the GEMS™ App for real-time/continuous monitoring. ECGs can be saved and then transferred to the Company's cloud-based SMART Monitoring ECG reading service when convenient or required. Once uploaded, ECGs can be reviewed and reported by physicians and feedback provided based on the ECG review findings.\nExecution of this agreement will allow both companies to co-market and distribute the handheld ECG devices through their respective distribution networks in overseas markets. Importantly, the SMART Monitoring licensing component of the agreement will see BORSAM actively promote access and use of CardioComm Solutions' ECG reading service as a device feature enhancement.\nAs a result of this agreement, CardioComm Solutions stands to realize new revenue streams from two sources. Devices currently manufactured by and sold through existing BORSAM-brokered North American and overseas sales channels will be charged a one-time GEMS™ Smartphone App download fee. Once devices are connected to the SMART Monitoring ECG reading service, additional and recurrent revenue will be generated through use of the service. BORSAM will stand to see higher device...